Literature DB >> 10431702

Role of hepatic, intrahepatic and hepatoenteral nerves in the regulation of carbohydrate metabolism and hemodynamics of the liver and intestine.

K Jungermann1, F Stümpel.   

Abstract

The liver as an effector organ is the major glucose reservoir, the utilization of which is controlled by hormones but also by hepatic sympathetic nerves. The liver as a sensory organ detects a glucose concentration gradient between the hepatic artery and the portal vein by intrahepatic sensory-effector nerves, generating a cholinergic signal for an insulin-dependent net hepatic glucose uptake. The liver senses the insulin concentration by hepatoenteral sensory-effector nerves, generating a cholinergic signal to increase glucose absorption in the intestine and thus its coordinated utilization in liver, muscle and adipose tissue.

Entities:  

Mesh:

Year:  1999        PMID: 10431702

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  Synaptophysin: A novel marker for human and rat hepatic stellate cells.

Authors:  D Cassiman; J van Pelt; R De Vos; F Van Lommel; V Desmet; S H Yap; T Roskams
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 2.  Regulation of hepatic glucose uptake and storage in vivo.

Authors:  Mary Courtney Moore; Katie C Coate; Jason J Winnick; Zhibo An; Alan D Cherrington
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 3.  Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

4.  Ontogenic development of nerve fibers in human fetal livers: an immunohistochemical study using neural cell adhesion molecule (NCAM) and neuron-specific enolase (NSE).

Authors:  Tadashi Terada
Journal:  Histochem Cell Biol       Date:  2014-10-18       Impact factor: 4.304

5.  Ontogeny of human intrahepatic innervation.

Authors:  Dina G Tiniakos; Joseph Mathew; Christos Kittas; Alastair D Burt
Journal:  Virchows Arch       Date:  2008-01-15       Impact factor: 4.064

6.  Effect of functional sympathetic nervous system impairment of the liver and abdominal visceral adipose tissue on circulating triglyceride-rich lipoproteins.

Authors:  Michael F La Fountaine; Christopher M Cirnigliaro; Steven C Kirshblum; Cristin McKenna; William A Bauman
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

7.  A Four Month Randomized Controlled Trial on the Efficacy of Once-daily Fenofibrate Monotherapy in Persons with Spinal Cord Injury.

Authors:  Michael F La Fountaine; Christopher M Cirnigliaro; Joshua C Hobson; Alexander T Lombard; Adam F Specht; Trevor A Dyson-Hudson; Steven C Kirshblum; William A Bauman
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

Review 8.  Vagal mechanisms as neuromodulatory targets for the treatment of metabolic disease.

Authors:  Hans-Rudolf Berthoud; Winfried L Neuhuber
Journal:  Ann N Y Acad Sci       Date:  2019-07-03       Impact factor: 5.691

9.  Establishing a threshold to predict risk of cardiovascular disease from the serum triglyceride and high-density lipoprotein concentrations in persons with spinal cord injury.

Authors:  Michael F La Fountaine; Christopher M Cirnigliaro; Joshua C Hobson; Trevor A Dyson-Hudson; Cristin Mc Kenna; Steven C Kirshblum; Ann M Spungen; William A Bauman
Journal:  Spinal Cord       Date:  2018-08-08       Impact factor: 2.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.